Achromatopsia as a potential candidate for gene therapy.

Abstract excerpt

Achromatopsia is an autosomal recessive retinal disease involving loss of cone function that afflicts approximately 1 in 30,000 individuals. Patients with achromatopsia usually have visual acuities lower than 20/200 because of the central vision loss, photophobia, complete color blindness and reduced cone-mediated electroretinographic (ERG) amplitudes. Mutations in three genes have been found to be the primary...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Color Vision Defects
• Share to Cyclic Nucleotide-Gated Cation Channels